HLS Therapeutics, Inc. (HLS.TO)
3.84
+0.15
(+4.06%)
CAD |
TSX |
Aug 25, 16:00
HLS Therapeutics Debt to Equity Ratio : 0.7586 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7586 |
| March 31, 2026 | 0.75 |
| December 31, 2025 | 0.8079 |
| September 30, 2025 | 0.8761 |
| June 30, 2025 | 0.8349 |
| March 31, 2025 | 0.9543 |
| December 31, 2024 | 0.9314 |
| September 30, 2024 | 0.865 |
| June 30, 2024 | 1.004 |
| March 31, 2024 | 0.9554 |
| December 31, 2023 | 0.8969 |
| September 30, 2023 | 0.8912 |
| June 30, 2023 | 0.8442 |
| March 31, 2023 | 0.8007 |
| December 31, 2022 | 0.7768 |
| September 30, 2022 | 0.7585 |
| June 30, 2022 | 0.6346 |
| March 31, 2022 | 0.595 |
| December 31, 2021 | 0.607 |
| September 30, 2021 | 0.6074 |
| June 30, 2021 | 0.6055 |
| March 31, 2021 | 0.6268 |
| December 31, 2020 | 0.6449 |
| September 30, 2020 | 0.6578 |
| June 30, 2020 | 0.5491 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5527 |
| December 31, 2019 | 0.5996 |
| September 30, 2019 | 0.5117 |
| June 30, 2019 | 0.5054 |
| March 31, 2019 | 0.6293 |
| December 31, 2018 | 0.6246 |
| September 30, 2018 | 0.6011 |
| June 30, 2018 | 0.6924 |
| March 31, 2018 | 0.7255 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Bausch Health Cos., Inc. | -11.73 |
| Cipher Pharmaceuticals, Inc. | 0.0027 |
| BioSyent, Inc. | 0.0685 |
| Revive Therapeutics Ltd. | -0.0176 |
| Knight Therapeutics, Inc. | 0.0429 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 182.38M |
| Total Liabilities (Quarterly) | 104.01M |
| Shareholders Equity (Quarterly) | 78.37M |
| Current Ratio | 1.049 |
| Net Debt Paydown Yield | 4.68% |